Abstract
Current demographic trends indicate that there is a growing number of older population groups worldwide, which is associated with an increase of chronic neurological disorders such as Parkinson’s disease that burdens the country’s healthcare system. Therefore there is an urgent call for developing efficient strategies which could reduce the healthcare costs and meet the demand of older people affected by these chronic neurological diseases at affordable cost. One of such approaches is the exploitation of a new emerging platform in the form of Internet of Things (IoT), which takes advantage of the connection of any physical object, for example a smartphone, to the Internet. The purpose of this study is to explore the use of IoT in the management of Parkinson’s disease (PD), specifically in its assessment, diagnostics, and treatment. The methods used in this study include a literature review of available sources found in the world’s acknowledged databases Web of Science, Scopus, PubMed, and ScienceDirect, as well as the methods of comparison and evaluation of the findings from the selected studies. The findings show that IoT may serve as an appropriate healthcare platform. IoT seems to be efficient, cost-effective and affordable approach in the management of chronic neurological disorders such as PD. However, more research has to be done by conducting more randomized controlled trials with larger samples of subjects in the area of the use of IoT in PD, as well as in other chronic neurological diseases.
Similar content being viewed by others
References
Dementia statistics. 2017. https://www.alz.co.uk/research/statistics. Accessed 26 Feb 2017.
Parkinson’s Disease Foundation. Statistics on Parkinson’s. 2017. http://www.pdf.org/en/parkinson_statistics. Accessed 26 Feb 2017.
Chang E. Parkinson’s and Alzheimer’s diseases: similar but very different. 2012. http://www.alznyc.org/nyc/newsletter/fall2012/06.asp#.VZ5-x7dT85s. Accessed 26 Feb 2017.
Houghton D, Hurtig H, Met S, Brandabur M. Parkinson’s disease: medications. 2015. http://www3.parkinson.org/site/DocServer/Medications.pdf?docID=185. Accessed 26 Feb 2017.
Blanchet P. Speech disorders in individuals with Parkinson’s disease. 2015. http://www.nysslha.org/i4a/pages/index.cfm?pageid=3519. Accessed 26 Feb 2017.
Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–42.
Parkinson’s Disease Foundation. Progression. 2015. http://www.pdf.org/en/progression_parkinsons. Accessed 26 Feb 2017.
Hamer M, Chida Y. Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med. 2009;39(1):3–11.
Zanini S, Tavano A, Fabbro F. Spontaneous language production in bilingual Parkinson’s disease patients: evidence of greater phonological, morphological and syntactic impairments in native language. Brain Lang. 2010;113(2):84–9.
Obeso I, Casabona E, Bringas ML, Alvarez L, Jahanshahi M. Semantic and phonemic verbal fluency in Parkinson’s disease: influence of clinical and demographic variables. Behav Neurol. 2012;25:111–8.
Hackney ME, Earhart GM. Effects of dance on movement control in Parkinson’s disease: a comparison of argentine tango and American ballroom. J Rehabil Med. 2009;41(6):475–81.
Klimova B, Maresova P, Kuca K. Non-pharmacological approaches to the prevention and treatment of Alzheimer’s disease with respect to the rising treatment costs. Curr Alzheimer Res. 2016;13:1249–58.
Maresova P, Klimova B, Novotny M, Kuca K. Alzheimer’s disease and Parkinson’s diseases: expected economic impact on Europe – a call for a uniform European strategy. J Alzheimers Dis. 2016;54:1123–33.
Pasluosta CF, Gassner H, Winkler J, Klucken J, Eskofier BM. An emerging era in the management of Parkinson’s disease: wearable technologies and the internet of things. IEEE J Biomed Health Inform. 2015:2168–2194
Gabbai A. Kevin Ashton describes the internet of things: the innovator weighs in on what human life will be like a century from now, Smithonian, no. 2015.
Brown E. Who needs the Internet of Things. 2016. https://www.linux.com/news/who-needs-internet-things. Accessed 26 Feb 2017.
Zanella A, Bui N, Castellani A, Vangelista L, Zorzi M. Internet of things for smart cities. IEEE Internet Things J. 2014;1(1):22–32.
Global Standards Initiative Internet of Things. 2016. http://www.itu.int/en/ITU-T/gsi/iot/Pages/default.aspx. Accessed 26 Feb 2017.
Meola A. What is the internet of things (IoT)? 2016. https://www.linux.com/news/who-needs-internet-things. Accessed 26 Feb 2017.
Meola A. Internet of things in healthcare: information technology in health. 2016. http://www.businessinsider.com/internet-of-things-in-healthcare-2016-8. Accessed 26 Feb 2017.
Bauer H, Patel M, Veira J. The internet of things: sizing up the opportunity [internet]. New York: McKinsey & Company. 2016. http://www.mckinsey.com/industries/high-tech/our-insights/the-internet-of-things-sizing-up-the-opportunity. Accessed 26 Feb 2017.
Dimitrov DV. Medical internet of things and big data in healthcare. Healthc Inform Res. 2016;22(3):156–63.
Istepanian R, Hu S, Philip N, Sungoor A. The potential of internet of m-health things "m-IoT" for non-invasive glucose level sensing. Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC); 2011.
Patel K. 6 benefits of IoT for hospitals and healthcare. 2017. https://www.ibm.com/blogs/internet-of-things/6-benefits-of-iot-for-healthcare/. Accessed 26 Feb 2017.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic review and meta-analysis: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Sanchez Rodriguez MT, Vazquez SC, Martin Casas P, Cano de la Cuerda R. Neurorehabilitation and apps: a systematic review of mobile applications. Neurologia. 2015.
Del Din S, Godfrey A, Mazza C, Lord S, Rochester L. Free-living monitoring of Parkinson’s disease: lessons from the field. Mov Disord. 2016;31(9):1293–313.
Kefaliakos A, Pliakos I, Charalampidou M, Diomidous M. Wireless monitoring for patients with cardiovascular diseases and Parkinson’s disease. Stud Health Technol Inform. 2016;226:87–90.
Szydlo T, Konieczny M. Mobile and wearable devices in an open and universal system for remote patient monitoring. Microprocess Microsyst. 2016;46(A):44–54.
Dai H, Zhang P, Lueth TC. Quantitative assessment of parkinsonian tremor based on an inertial measurement unit. Sensors. 2015;15(10):25055–71.
Carignan B, Daneault JF, Duval C. Measuring tremor with a smartphone. Methods Mol Biol. 2015;1256:359–74.
Rossi-Izquierdo M, Basta D, Rubio-Rodriguez JP, Santos-Perez S, Ernst A, Sesar-Ignacio A, et al. Is posturography able to identify fallers in patients with Parkinson’s disease? Gait Posture. 2004;40(1):53–7.
Ellis RJ, Ng YS, Zhu S, Tan DN, Anderson B, Schlaug G, et al. A validated smartphone-based assessment of gait and gait variability in Parkinson’s disease. PLoS One. 2015;10(10):e0141694.
Ferrari A, Ginis P, Hardegger M, Casamassima F, Rocchi L, Chiari L. A mobile Kalman-filter based solution for the real-time estimation of spatial-temporal gait parameters. IEEE Trans Neural Syst Rehabil Eng. 2016;24(7):764–73.
Kostikis N, Hristu-Vasakelis D, Arnaoutoglon M, Kotsavasiloglou C. A smartphone-based tool for assessing Parkinson hand tremor. IEEE J Biomed Health Inform. 2015;19(6):1835–42.
Marx S, Respondek G, Stamelou M, Dowiasch S, Stoll J, Bremmer F, et al. Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson’s disease. Front Behav Neurosci. 2012;6:88.
Ozinga SJ, Machado AG, Miller Koop M, Rosenfeldt AB, Alberts JL. Objective assessment of postural stability in Parkinson’s disease using mobile technology. Mov Disord. 2015;30(9):1214–21.
Lopez WO, Higuera CA, Fonoff ET, Souza Cde O, Albicker U, Martinez JA. Listenmee and Listenmee smartphone application: synchronizing walking to rhythmic auditory cues to improve gait in Parkinson’s disease. Hum Mov Sci. 2014;37:147–56.
Lakshminarayana R, Wang D, Burn D, Chandhuri KR, Cummins G, Galtrey C, et al. Smartphone– and internet-assisted self-management and adherence tools to manage Parkinson’s disease (SMART-PD): study protocol for a randomized controlled trial (v7; 15 august 2014). Trials. 2014;15:374.
Funding
This review study is supported by the SPEV project 2104/2018 run at the Faculty of Informatics and Management, University of Hradec Kralove, Czech Republic.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors, so that informed consent from all individual participants was not needed for this study.
Rights and permissions
About this article
Cite this article
Klímová, B., Kuča, K. Internet of things in the assessment, diagnostics and treatment of Parkinson’s disease. Health Technol. 9, 87–91 (2019). https://doi.org/10.1007/s12553-018-0257-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12553-018-0257-z